Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation – Clinical Daily News
Drugmaker Roche’s experimental Alzheimer’s drug gantenerumab has been granted breakthrough remedy designation from the Meals and Drug Administration, opening a ...